14-16
Dec
2026
CPHI Middle East 2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
H1.B40
Spectropharma
About Spectropharma
-
Country/Region:Saudi Arabia
-
On CPHI since:2024
Company types
Primary activities
Products from Spectropharma (5)
-
Product Acumen 10,18,25,40& 60 Mg
Atomoxetine is an SNRI medicine used to treat attention deficit hyperactivity disorder (ADHD) to help improve attention and reduce hyperactivity and impulsiveness. Atomoxetine is thought to work by selectively blocking a protein (pre-synaptic norepinephrine transporter) that affects chemicals in the brain ... -
Product Eptop 25,50&100 Mg
Topiramate is used alone or with other medications to treat certain types of seizures in adults and children at least 2 years old. -
Product Oncology line
IRCAN is irinotecan hydrochloride DAZASPECT is Azacitidine PENMATE is Pemetrexed SPECTRODOCE is Docetaxel -
Product Paricalcitol Spectro
Paricalcitol is a synthetic (man-made) form of vitamin D. Vitamin D is important for the absorption of calcium from the stomach and for the functioning of calcium in the body. Paricalcitol is used to help maintain healthy levels of parathyroid hormone in people with chronic kidney disease who are on dialysis. -
Product Vtreat
Vildagliptin is indicated in the treatment of type-2 diabetes mellitus in adults as monotherapy or in combination with metformin or a sulphonyl urea.
Spectropharma Resources (1)
-
Brochure Spectropharma brochure
WE ARE READY




